Elusys Therapeutics INC FKA Nighthawk Biosciences, INC.
Biotechnology/pharmaceutical & biomanufacturing company
Based in NC
AI Overview
With $1.8M in lobbying spend across 13 quarterly filings, Elusys Therapeutics INC FKA Nighthawk Biosciences, INC is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2023 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $490K |
| 2024 | $540K |
| 2025 | $770K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Elusys Therapeutics INC FKA Nighthawk Biosciences, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Defense, Budget/Appropriations
Healthcare, pharmaceutical, and emergency preparedness issues
PAHPA, NDAA, Appropriations issues relevant to healthcare, biodefense, infectious disease, biomanufacturing.
National Defense Authorization Act for 2024 Pandemic and All Hazards Preparedness Act Reauthorization 2024 Appropriations Issues Other issues related to biodefense/Preparedness/biomanufacturing
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.